Cannabis2 years ago
Evogene Reports Second Quarter 2022 Financial Results
Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market segments, announced today...